Prosperity Drugs Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 7.00 Cr
as on 24-10-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 40.76 Cr
as on 24-10-2024
- Revenue -3.68%
(FY 2023)
- Profit 64.91%
(FY 2023)
- Ebitda 78.03%
(FY 2023)
- Net Worth -35.10%
(FY 2023)
- Total Assets 1.14%
(FY 2023)
About Prosperity Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹40.76 Cr.
Banshidhar Kanhaiyalal, Murlidhar Kanhaiyalal, Parminder Bansal, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290HP2019PTC007481
- Company No.
007481
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prosperity Drugs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Banshidhar Kanhaiyalal  | Director | 04-Jun-2019 | Current |
| Murlidhar Kanhaiyalal | Director | 04-Jun-2019 | Current |
| Parminder Bansal | Director | 04-Jun-2019 | Current |
| Bharat Bansal | Director | 04-Jun-2019 | Current |
Financial Performance of Prosperity Drugs.
Prosperity Drugs Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.68% decrease. The company also saw a substantial improvement in profitability, with a 64.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prosperity Drugs?
In 2023, Prosperity Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Acme Therapeutics (I) Private LimitedActive 23 years 9 monthsBanshidhar Kanhaiyalal is a mutual person
Evets Drugs Private LimitedActive 1 year 6 monthsBanshidhar Kanhaiyalal and Murlidhar Kanhaiyalal are mutual person
- Sriram Healthcare Private LimitedActive 16 years 9 months
Banshidhar Kanhaiyalal and Murlidhar Kanhaiyalal are mutual person
- Evets Packaging Private LimitedActive 7 years 10 months
Banshidhar Kanhaiyalal and Murlidhar Kanhaiyalal are mutual person
- Evets Glass & Polymer Private LimitedActive 3 years 4 months
Banshidhar Kanhaiyalal and Murlidhar Kanhaiyalal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Oct 2020 | ₹40.76 Cr | Open |
How Many Employees Work at Prosperity Drugs?
Prosperity Drugs has a workforce of 150 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prosperity Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prosperity Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
